- Tytuł:
- A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
- Autorzy:
- Źródło:
- In European Urology June 2023 83(6):486-494
Czasopismo naukowe